About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about AstraZeneca PLC

Recent news which mentions AstraZeneca PLC

< Previous 1 2 3 4 5 Next >
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Health & Science Health care industry Science
From CNBC.com News
CNBC's Inside India newsletter: A slowing economy hasn't dimmed India's allure at Davos
Tags Economic events World Politics World Economy
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags US: News GSK plc Abbvie Inc
From CNBC.com News
J&J says its lung cancer drug combination keeps people alive longer
Tags Health care industry Johnson & Johnson AstraZeneca PLC
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Merck & Co Inc AstraZeneca PLC Pharmaceuticals
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Healthy Returns AstraZeneca PLC Biotech and Pharmaceuticals
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags stocks Berkshire Hathaway Inc Boeing Co
From CNBC.com News
Cramer's Lighting Round: 'I'm not going to recommend' Altria
Tags Stock Picks Investment Strategy U/S/ Markets
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Tags AstraZeneca PLC Healthy Returns Social issues
From CNBC.com News
The 2 things that will drive the stock market after last week's Trump-Fed rally
Tags ICL Group Ltd Breaking News: Markets Industrials
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Tags Health care industry Sanofi SA Pfizer Inc
From CNBC.com News
Cerebras IPO has 'too much hair' as AI chipmaker tries to sell Wall Street on Nvidia alternative
Tags NVIDIA Corp Breaking News: Technology AstraZeneca PLC
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Tags Bristol/Myers Squibb Co Health care industry Eli Lilly and Co
From CNBC.com News
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
Tags AstraZeneca PLC Europe News Companies
From CNBC.com News
AstraZeneca says staff detained in China amid reports of a drug-import investigation
Tags Pharmaceuticals Business Biotechnology
From CNBC.com News
India and Singapore agree to cooperate on chips as countries seek to strengthen partnership
Tags Asia News AstraZeneca PLC Asia Politics
From CNBC.com News
India's Modi expected to usher in new era of bilateral agreements in Singapore visit
Tags Technology Breaking News: Technology Asia Economy
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Merck & Co Inc Abbvie Inc US: News
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags AstraZeneca PLC Healthy Returns Merck & Co Inc
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Merck & Co Inc Healthy Returns AstraZeneca PLC
From CNBC.com News
Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030
Tickers CEO
Tags Investing Markets Mad Money
From CNBC.com News
Cramer's Lighting Round: 'You've got a winner' with Astra Zeneca
Tags Business News stocks Business
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Investment strategy Health care industry Novartis AG
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags AstraZeneca PLC World News Novo Nordisk A/S
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Zealand Pharma A/S Business News Companies
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Teva Pharmaceutical Industries Ltd GSK plc AstraZeneca PLC
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
Tags GSK plc Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
Tags Healthy Returns AstraZeneca PLC Merck & Co Inc
From CNBC.com News
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.